PROFILE: Paula Salmikangas, chair of the EMA's Advanced Therapies Committee, on handicrafts, berry-picking and the first stem cell therapy
This article was originally published in Scrip
The European Medicines Agency's Committee for Advanced Therapy Medicinal Products (CAT) evaluates the quality, safety and efficacy of ATMPs. Since February 2014, the CAT has been chaired by senior Finnish regulator Paula Salmikangas. Here, Dr Salmikangas talks to Francesca Bruce about the pitfalls of rushing a product from bench to patient, the value to companies of talking to regulators – and her passion for berry-picking and the Phantom of the Opera.